Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalMarket CapitalizationNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Sales

cbdMD (YCBD) EBITDA Margin: 2016-2025

Historic EBITDA Margin for cbdMD (YCBD) over the last 9 years, with Sep 2025 value amounting to -14.53%.

  • cbdMD's EBITDA Margin fell 758.00% to -14.53% in Q3 2025 from the same period last year, while for Sep 2025 it was -11.27%, marking a year-over-year increase of 537.00%. This contributed to the annual value of -11.27% for FY2025, which is 537.00% up from last year.
  • According to the latest figures from Q3 2025, cbdMD's EBITDA Margin is -14.53%, which was up 26.03% from -19.64% recorded in Q2 2025.
  • In the past 5 years, cbdMD's EBITDA Margin registered a high of -1.69% during Q4 2024, and its lowest value of -373.55% during Q2 2022.
  • For the 3-year period, cbdMD's EBITDA Margin averaged around -38.71%, with its median value being -19.64% (2025).
  • Per our database at Business Quant, cbdMD's EBITDA Margin slumped by 31,475bps in 2022 and then surged by 34,533bps in 2023.
  • Over the past 5 years, cbdMD's EBITDA Margin (Quarterly) stood at -255.10% in 2021, then spiked by 19,027bps to -64.84% in 2022, then spiked by 4,501bps to -19.83% in 2023, then soared by 1,814bps to -1.69% in 2024, then plummeted by 758bps to -14.53% in 2025.
  • Its last three reported values are -14.53% in Q3 2025, -19.64% for Q2 2025, and -10.23% during Q1 2025.